MEI Pharma

IPO

Bringing Litecoin to public markets so millions can gain exposure to one of the world’s most enduring digital assets.

Public · San Diego, United States · Founded 2000 · $202.5M raised

Employees
11–50
Founded
2000
Business Model
B2B
Total Funding
$202.5M
Last Round
$100.0M Private EquityJul 2025
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

MEI Pharma (Nasdaq: MEIP) is a clinical-stage pharmaceutical company committed to developing novel and differentiated cancer therapies. The company leverages its extensive oncology expertise to advance a portfolio of small-molecule drug candidates targeting treatment-resistant cancers, with the goal of improving outcomes for patients with unmet medical needs.

Summary

MEI Pharma is a Biotech company based in San Diego, United States, founded in 2000. It has raised $202.5M in total across 3 rounds, most recently a $100.0M Private Equity round in Jul 2025. Investors include Vivo Capital, Charlie Lee and GSR.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate EquityJul 2025
$100.0M

Sign up to see all 4 events

Funding: Venture Round through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MEI Pharma on Indexed.vc
<a href="https://indexed.vc/companies/mei-pharma"><img src="https://indexed.vc/api/badge/company/mei-pharma" alt="MEI Pharma on Indexed.vc" width="260" height="76" /></a>